We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Opdivo
Australian Public Assessment Report
Device/Product Name
Opdivo
Active ingredients
nivolumab
AusPAR Date
Published
Submission Number
PM-2022-00374-1
Submission Type
Extension of indications
Decision
Approved